GTR Home > Tests > Search results - CN029323[DISCUI]

Apply filters

Showing tests for all 1238 conditions

Compare labs

Your search term can be found in tests with a total of 1238 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for CN029323[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 27 tests for 1238 conditions in 13 labs

CBrugada syndrome type 1

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPan Cardiomyopathy Panel (62 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (103)
Total targets (62)

CDCM/Arrhythmogenic Cardiomyopathy Panel (53 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (97)
Total targets (53)

CBrugada Syndrome 1 via the SCN5A Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCardiomyopathy and Arrhythmia Panel, Sequencing (85 Genes) and Deletion/Duplication (83 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CCardiomyopathy and Arrhythmia Deletion/Duplication, 83 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Total conditions (151)
Total targets (83)

CSCN5A

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)

CHypertrophic Cardiomyopathy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (150)
Total targets (63)

CBrugada Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (8)

CBrugada syndrome

Lab: Invitae San Francisco, California, United States
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)
Total targets (10)

CSudden Cardiac Arrest (SCA): Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (30)
Total targets (10)

CBrugada Syndrome: Sequencing Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (18)
Total targets (8)

CDilated Cardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (74)
Total targets (38)

CCardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (228)
Total targets (104)

CNuclear-Mito NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (601)
Total targets (504)

CSudden Death Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Total conditions (185)
Total targets (68)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (598)
Total targets (343)

CAtrial Fibrillation NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (75)
Total targets (23)

CLong QT syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (40)
Total targets (13)

CPan-Cardio NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (239)
Total targets (101)

Showing 1 to 20 of 27 tests for 1238 conditions in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.